Pam Cheng, the executive vice president of operations and IT at AstraZeneca, is leading the pharmaceutical industry in a shift towards sustainability. As both the company’s chief sustainability officer and a staunch advocate for environmental responsibility, Cheng believes that a healthy planet is essential for promoting overall well-being.
Since joining AstraZeneca in 2015, Cheng has spearheaded efforts to make the company a leader in sustainability within the pharmaceutical industry. One of her major achievements is AstraZeneca’s participation in the Science-Based Target Initiative, where it was one of the first seven global companies to have its greenhouse gas emissions targets verified. The company has also launched the ambitious $1 billion Ambition Zero Carbon program, aimed at reducing greenhouse gas emissions. AstraZeneca has already achieved a 68% reduction in emissions and aims to reach 98% by 2025, with plans to transition its entire vehicle fleet to electric by 2026.
Cheng has also implemented innovative solutions at AstraZeneca, such as converting one of the company’s manufacturing plants to biomethane, a renewable energy source made from food and farm waste. This investment in anaerobic digestion plants demonstrates a commitment to a circular economy where waste is reused and recycled, minimizing environmental impact. Cheng is dedicated to driving both the health of people and the health of the planet through her work at AstraZeneca.
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/3N5HK3VV6BFSFE72RCAQO5GYNA.jpg)
